Broadcom crushed earnings but got dragged down by the jobs report — buy the dip in AVGO

Verdict: the $63B pipeline case is real, but Broadcom's tape says wait

Over the next three months this is a wait: the business thesis is credible, but neither the momentum trigger nor the ownership picture supports entering today. The strongest support is the reported $63 billion financing package from banks and Blackstone specifically for Broadcom chips for Anthropic (per Reuters, October 26, 2026), arriving alongside a quarter ended August 2, 2026 that grew revenue 33.4% sequentially to $29.6B with a 53.9% operating margin. The strongest counterweight is provisional ownership data for the period ending September 30, 2026 showing roughly $513.6 million of net insider open-market selling, plus a price already 32.7% below its range high at $323.93 — evidence the market may have priced much of this. A scope note: historical performance for the entry strategy was not measured because AVGO's raw and adjusted price series use different bases, so the rules are research conditions rather than a validated edge. We reassess when RSI recovers through 45 and price closes above the $343.22 21-day average, or when the next ownership filing confirms or reverses the selling.

Trade now

**Wait.** The business thesis is genuinely attractive — Broadcom's latest quarter (ended August 2, 2026) showed revenue of $29.6B, up 33.4% quarter over quarter, with net income up 40.6% to $13.1B and free cash flow of $13.7B. The idea argues a $63 billion financing package earmarked for Broadcom chips plus an AI-sentiment lift from Anthropic's IPO filing creates a fundamental demand pipeline. That is a solid case for owning the stock. But today's entry conditions are not met. The strategy requires four conditions together: price below the Bollinger middle band (currently met — price is $323.93 versus the band at $347.65), the 14-day RSI crossing above 45 (currently 30.7, well below), price crossing above the 21-day average (price sits $19.29 below it, at $343.22), and a MACD line/signal cross (nearly aligned). The pivotal condition is the momentum turn: RSI recovering through 45 alongside a close above the 21-day average. Concretely, "wait" means standing aside until RSI pushes above 45 and price closes above roughly $343 — both may take several sessions from an oversold reading of 30.7. The downside that matters: the stock is 32.7% below its range high, sits below both its 50-day and 200-day averages, and the latest ownership data shows net insider open-market selling of roughly $513.6 million, so momentum has been against the thesis. One scope note: historical performance for this strategy was not measured (AVGO's raw and adjusted price series use different bases), and no robust parameter setup was established — so the entry rules are research conditions, not a statistically validated edge. ### Technical details All values observed on the daily chart as of the October 27, 2026 computation; last close $323.93. **Entry (all four required):** - Price below the Bollinger (20) middle band: **met** — $323.93 versus $347.65. - RSI (14) crossing above 45: **far** — RSI is 30.7 and needs a gain of about 14 points. RSI is a 0–100 momentum gauge; readings under 30 signal oversold, above 70 overbought. - Price crossing above the 21-day average: **far** — $323.93 versus $343.22, about 6% below. - MACD (12, 26, 9) line crossing above its signal line: **near** — currently at -9.54, aligned with the threshold. **Exits:** RSI above 75 or a 90-bar holding period (signal exit); take profit near the first resistance level at $339.58 or at a +4.0% unrealized gain; stop loss on a close below the second-ranked support at $330.01, a hard -2.0% stop, whichever hits first. Position sizing is fixed-risk at 2.0% per trade, capped at 25% of the portfolio. At the current price the nearest reward target ($339.58) is roughly 2.7 points of upside below the 4% cap, while the $330.01 support stop is about 1.8 points below — a thin reward-to-risk profile until price recovers through the average, which is another reason to wait for the trigger rather than anticipate it.

A Committed $63B Buyer Plus Accelerating Financials Backs the Bull Case

Takeaway: the thesis rests on two things — a huge, named financing commitment earmarked for Broadcom silicon (per Reuters, banks and Blackstone lined up $63B to finance Broadcom chips for Anthropic), and a fundamentals trajectory that has been accelerating into the news — and both are genuinely supported by the supplied data. ### The catalyst is a named buyer, not vague AI optimism The Reuters report (published October 26, 2026) describes $63B of financing from Wall Street banks and Blackstone specifically to fund Broadcom chips for Anthropic — a financing…

Scores

• Conviction score breakdown: 56
• Thesis support: 72
• Trade readiness: 30
• Risk quality: 45
• Fundamentals trend: 78

Watch items

• AVGO — RSI (14)
• AVGO — Close vs 21-day EMA
• AVGO — MACD (12,26,9) line vs signal line
• AVGO — Close vs rank-2 support
• AVGO — Insider net open-market selling